In conclusion, our study unveils novel insights into the mechanism governing neuroimmune interactions in psoriasis, emphasizing the therapeutic potential of targeting ASIC3 in chronic inflammatory skin diseases. The gene discussed is ASIC3; the disease is psoriasis.